Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Volavka

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Brain Structure & Function|April 23, 2011
Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggressionStephen D Ginsberg, Shaoli Che, Audrey Hashim, et al.
Schizophrenia Research|June 2, 2005
Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluationJan Volavka, Karen A Nolan, Linda Kline, et al.
The American Journal of Psychiatry|February 2, 2002
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorderJan Volavka, Pal Czobor, Brian Sheitman, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidolJan Volavka, Pal Czobor, Karen Nolan, et al.
The Journal of Clinical Psychiatry|May 4, 2004
Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophreniaJean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al.
The American Journal of Psychiatry|February 4, 2003
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychoticsJean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al.
Journal of Clinical Psychopharmacology|November 16, 2007
Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trialsDonald C Goff, Richard Keefe, Leslie Citrome, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 27, 2004
COMT158 polymorphism and hostilityJan Volavka, James L Kennedy, Xingqun Ni, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neurolepticsKaren A Nolan, Pál Czobor, Leslie L Citrome, et al.
CNS Spectrums|July 10, 2020
Deconstructing violence in acutely exacerbating psychotic patientsAndrea Nichtová, Jan Volavka, Jan Vevera, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Brain Structure & Function|April 23, 2011
Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggressionStephen D Ginsberg, Shaoli Che, Audrey Hashim, et al.
Schizophrenia Research|June 2, 2005
Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluationJan Volavka, Karen A Nolan, Linda Kline, et al.
The American Journal of Psychiatry|February 2, 2002
Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorderJan Volavka, Pal Czobor, Brian Sheitman, et al.
Journal of Clinical Psychopharmacology|June 23, 2004
Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidolJan Volavka, Pal Czobor, Karen Nolan, et al.
The Journal of Clinical Psychiatry|May 4, 2004
Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophreniaJean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al.
The American Journal of Psychiatry|February 4, 2003
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychoticsJean-Pierre Lindenmayer, Pal Czobor, Jan Volavka, et al.
Journal of Clinical Psychopharmacology|November 16, 2007
Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trialsDonald C Goff, Richard Keefe, Leslie Citrome, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 27, 2004
COMT158 polymorphism and hostilityJan Volavka, James L Kennedy, Xingqun Ni, et al.
Journal of Clinical Psychopharmacology|May 17, 2006
Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neurolepticsKaren A Nolan, Pál Czobor, Leslie L Citrome, et al.
CNS Spectrums|July 10, 2020
Deconstructing violence in acutely exacerbating psychotic patientsAndrea Nichtová, Jan Volavka, Jan Vevera, et al.
Pageof 10